Your browser is no longer supported. Please, upgrade your browser.
A Agilent Technologies, Inc. daily Stock Chart
Agilent Technologies, Inc.
IndexS&P 500 P/E35.57 EPS (ttm)2.42 Insider Own0.50% Shs Outstand310.00M Perf Week5.14%
Market Cap26.72B Forward P/E24.30 EPS next Y3.55 Insider Trans-9.38% Shs Float308.51M Perf Month13.02%
Income764.00M PEG4.36 EPS next Q0.64 Inst Own89.50% Short Float1.70% Perf Quarter10.33%
Sales5.24B P/S5.10 EPS this Y26.10% Inst Trans1.10% Short Ratio2.01 Perf Half Y8.92%
Book/sh15.64 P/B5.51 EPS next Y15.84% ROA11.70% Target Price81.17 Perf Year28.47%
Cash/sh3.95 P/C21.79 EPS next 5Y8.17% ROE22.00% 52W Range61.13 - 90.64 Perf YTD1.02%
Dividend0.72 P/FCF40.48 EPS past 5Y37.50% ROI15.20% 52W High-4.92% Beta1.10
Dividend %0.84% Quick Ratio1.30 Sales past 5Y5.00% Gross Margin53.90% 52W Low40.98% ATR2.49
Employees16300 Current Ratio1.60 Sales Q/Q5.70% Oper. Margin18.00% RSI (14)67.56 Volatility2.39% 2.72%
OptionableYes Debt/Eq0.51 EPS Q/Q-59.80% Profit Margin20.50% Rel Volume0.72 Prev Close86.13
ShortableYes LT Debt/Eq0.37 EarningsMay 21 AMC Payout18.80% Avg Volume2.62M Price86.18
Recom2.20 SMA208.01% SMA5014.04% SMA20010.44% Volume1,917,594 Change0.06%
Feb-24-20Downgrade Needham Buy → Hold
Jan-08-20Initiated Wells Fargo Overweight $100
Jan-07-20Initiated Citigroup Neutral $85
Nov-26-19Reiterated Needham Buy $92 → $85
Nov-15-19Initiated Stifel Hold
Oct-18-19Downgrade UBS Buy → Neutral $82
Jul-16-19Downgrade BofA/Merrill Buy → Neutral $76
Jul-15-19Downgrade Barclays Overweight → Equal Weight $86 → $78
Jun-11-19Initiated Piper Jaffray Overweight $83
May-30-19Initiated Wolfe Research Peer Perform
Mar-15-19Initiated UBS Buy $92
Feb-25-19Reiterated Needham Buy $77 → $88
Feb-21-19Reiterated BofA/Merrill Buy $78 → $87
Jan-03-19Initiated Needham Buy $77
Nov-12-18Downgrade Cleveland Research Buy → Neutral
Apr-09-18Upgrade Goldman Neutral → Buy
Nov-21-17Reiterated Barclays Overweight $67 → $71
Sep-26-17Resumed Goldman Neutral $68
Jul-13-17Upgrade Wells Fargo Market Perform → Outperform
Mar-15-17Upgrade Morgan Stanley Equal-Weight → Overweight
May-28-20 06:13AM  Billionaire Ackman Exits Berkshire Hathaway, Blackstone To Fund Opportunities SmarterAnalyst
May-27-20 11:00AM  Agilent to Present at Jefferies Virtual Healthcare Conference Business Wire
May-25-20 03:50AM  Agilent Up 5% On Solid Revenue Beat, But Top Analysts Stay Cautious SmarterAnalyst
May-23-20 10:43AM  Coronavirus update: U.S. death toll approaches 100,000 as CDCs testing practices are criticized by health experts MarketWatch
12:35AM  Edited Transcript of A earnings conference call or presentation 21-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-22-20 09:36AM  Agilent's (A) Q2 Earnings Beat Estimates, Revenues Down Y/Y Zacks +5.24%
01:00AM  Agilent Technologies Inc (A) Q2 2020 Earnings Call Transcript Motley Fool
May-21-20 05:25PM  Agilent Technologies (A) Beats Q2 Earnings and Revenue Estimates Zacks
04:24PM  Agilent shares rise after company tops earnings expectations MarketWatch
04:05PM  Agilent Reports Second-Quarter Fiscal Year 2020 Financial Results Business Wire
May-20-20 04:05PM  Agilent Announces Cash Dividend of 18 Cents Per Share Business Wire
12:53PM  Bill Ackman Adds 2 Stocks to Portfolio, Expands Agilent and Howard Hughes Stakes
May-19-20 01:00PM  Bill Ackman Bulks Up on Top Positions After $2.6 Billion Payoff
May-18-20 10:39AM  Agilent (A) Gears Up for Q2 Earnings: What's in the Cards? Zacks
May-16-20 09:15AM  Merck, Medtronic, and Other Health-Care Stocks Widely Owned by ESG Funds Outperform
May-15-20 08:15PM  Can Amazon Solve the Covid-19 Testing Challenge?
03:08PM  Agilent Technologies, Inc. -- Moody's announces completion of a periodic review of ratings of Agilent Technologies, Inc. Moody's
May-14-20 12:30PM  Earnings Preview: Agilent Technologies (A) Q2 Earnings Expected to Decline Zacks
May-12-20 08:00AM  Agilent Awards Trilogy Sciences with a Golden Ticket at LabCentral Business Wire
May-07-20 01:27PM  3 Stocks Growing Their Earnings Fast
May-06-20 03:06PM  Coronavirus update: U.S. death toll tops 71,000, as Trump backs off plan to wind down pandemic task force MarketWatch
May-05-20 08:09AM  Agilent Technologies, Inc. -- Moody's assigns P-2 rating to Agilent's new commercial paper program, affirms Baa2 rating, outlook stable Moody's
May-01-20 06:06AM  Did Agilent Technologies' (NYSE:A) Share Price Deserve to Gain 80%? Simply Wall St.
Apr-30-20 10:44AM  The Market Timing Secrets No One Talks About - April 30, 2020 Zacks
Apr-23-20 08:00AM  Agilent Receives FDA Approval for PD-L1 Companion Diagnostic on Dako Omnis Business Wire
Apr-22-20 08:00AM  Agilent Signs Sponsorship Agreement with My Green Lab Business Wire
Apr-17-20 09:50AM  Agilent Technologies Could Regain Its Former Peak
Apr-15-20 09:37AM  Agilent (A) Withdraws Q2 & FY20 View Amid Coronavirus Crisis Zacks
Apr-14-20 07:10PM  Top 1st-Quarter Buys of Jerome Dodson's Parnassus Fund
08:00AM  Agilent Technologies Provides Update on COVID-19 Impact; Sets Second-Quarter Earnings Call for May 21 Business Wire
Apr-07-20 08:51AM  Timing the Market, Is it Possible? - April 07, 2020 Zacks
Apr-06-20 08:39PM  Coronavirus Had Ackman Consider Liquidating Portfolio Bloomberg +5.60%
Apr-01-20 06:20AM  A Look At The Fair Value Of Agilent Technologies, Inc. (NYSE:A) Simply Wall St.
Mar-31-20 08:00AM  Agilent Introduces New Handheld Raw Material ID System for Pharmaceutical Manufacturers Business Wire
Mar-30-20 01:00PM  Agilent Technologies to Change Location of Annual Meeting Business Wire
08:00AM  Agilent Announces New Class 1 Triple Quadrupole LC/MS System Business Wire
Mar-27-20 12:20PM  Belk CEO confirms furloughs at corporate office American City Business Journals
08:44AM  Patriot's new CCO talks growth, acquisitions and coronavirus American City Business Journals
Mar-26-20 06:00AM  Agilent Technologies- Diagnostics and Life Sciences MoneyShow +6.84%
Mar-25-20 05:30PM  Bill Ackman Puts Part of His Personal Fortune in Covid-19 Testing Bloomberg
10:52AM  How Bill Ackman Turned $27 Million Into $2.6 Billion During the Coronavirus Crisis
Mar-22-20 10:15AM  What Apple, Microsoft, GE and other U.S. companies are saying about the coronavirus outbreak MarketWatch
Mar-20-20 05:50PM  Agilent Technologies (A) Gains As Market Dips: What You Should Know Zacks
Mar-19-20 03:38PM  6 Med-Tech and Medical-Device Stocks to Buy Kiplinger
11:30AM  Why Is Agilent (A) Down 19.3% Since Last Earnings Report? Zacks
Mar-18-20 04:05PM  Agilent Technologies Announces Cash Dividend of 18 Cents Per Share Business Wire
Mar-17-20 04:15PM  Agilent Technologies to Adjourn Annual Meeting Until April 17, 2020 Business Wire +9.84%
09:54AM  Yes, You Can Time the Market. Find out How - March 17, 2020 Zacks
Mar-16-20 08:00AM  Agilent Introduces CrossLab Connect Services for Lab-wide Asset Monitoring Business Wire -7.33%
Mar-12-20 08:00AM  Agilent Receives Two Scientists Choice Awards Business Wire -7.87%
Mar-11-20 09:25PM  Is Agilent Technologies Inc. (A) Going To Burn These Hedge Funds ? Insider Monkey -5.58%
Mar-06-20 03:06PM  The Grand Bohemian sets opening date in uptown American City Business Journals
Mar-03-20 03:30PM  6 Guru Stocks Trading With Low Price-Sales Ratios
08:00AM  Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research Business Wire
Mar-02-20 11:00AM  Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions Business Wire +6.36%
05:22AM  You Have To Love Agilent Technologies, Inc.'s (NYSE:A) Dividend Simply Wall St.
Feb-28-20 03:02PM  Colorado educators and companies team up to attract high schoolers into biotech American City Business Journals
08:00AM  Agilent Technologies Announces Webcasts for Investment Community Business Wire
Feb-27-20 11:33AM  Bill Ackman Continues to Chip Away at Largest Holding
12:30AM  Edited Transcript of A earnings conference call or presentation 18-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-21-20 10:15AM  Fitbit (FIT) Q4 Loss Wider Than Estimated, Revenues Lag Zacks
Feb-20-20 09:21AM  How to Time the Markets Like an Investing Pro - February 20, 2020 Zacks
Feb-19-20 01:19PM  Garmin's (GRMN) Q4 Earnings & Revenues Surpass Estimates Zacks
11:54AM  Coronavirus update: More than 75,000 cases and 2,000 deaths, Walmart predicts Q1 impact on EPS MarketWatch
07:41AM  Agilent (A) Q1 Earnings In Line With Estimates, Revenues Top Zacks
Feb-18-20 04:27PM  Agilent stock slips as coronavirus dings outlook MarketWatch
04:05PM  Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results Business Wire
03:57PM  Bill Ackman's Pershing Square: 4th-Quarter Update
11:03AM  Earnings Reports for the Week of Feb. 17-21 (SAM, WING, WMT) Kiplinger
06:39AM  GoDaddy (GDDY) Q4 Earnings Miss Estimates, Revenues Beat Zacks
Feb-16-20 03:00PM  Walmart, ViacomCBS, Deere, and Other Stocks for Investors to Watch This Week
Feb-14-20 05:06PM  Edited Transcript of A earnings conference call or presentation 14-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
08:56AM  TripAdvisor (TRIP) Beats Q4 Earnings & Revenue Estimates Zacks
08:50AM  Alibaba (BABA) Surpasses Q3 Earnings & Revenue Estimates Zacks
07:30AM  Australias Brambles, Irelands Accenture Are the Most Sustainable Companies Outside the U.S.
Feb-13-20 08:47AM  Applied Materials (AMAT) Q1 Earnings & Sales Top Estimates Zacks
Feb-12-20 11:54AM  Agilent Technologies Passes This Acid Test
09:30AM  Agilent (A) Gears Up for Q1 Earnings: What's in the Cards? Zacks
Feb-11-20 12:30PM  Agilent Technologies (A) Reports Next Week: Wall Street Expects Earnings Growth Zacks
08:21AM  Can Strong Cloud Growth Propel Alibaba's (BABA) Q3 Earnings? Zacks
Feb-10-20 11:58AM  Bill Ackman's Pershing Square Takes a Chip Off Chipotle Stake
05:01AM  7 Stocks Join the Dividend Aristocrats, and Two More Numbers to Know
Feb-07-20 10:00AM  Fortive (FTV) Earnings & Revenues Surpass Estimates in Q4 Zacks
Feb-06-20 05:17PM  Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation Business Wire
Feb-05-20 02:55PM  Bill Ackmans Hedge Fund Sold Its Starbucks Stock With a 73% Gain
01:09PM  Ackman's Pershing Square exits Starbucks, sticks by Chipotle, sees gains at Agilent Reuters
06:04AM  Our Take On Agilent Technologies, Inc.'s (NYSE:A) CEO Salary Simply Wall St.
Feb-04-20 02:32PM  Eaton Vance Exits Celgene, Trims Amgen Position
Jan-30-20 08:00AM  Keysight Technologies' Nersesian Reveals Key To Standalone Success Investor's Business Daily
Jan-29-20 10:00PM  Agilent Teams with Indian Institute of Technology Delhi to Enhance Biotherapeutics Business Wire
10:01AM  How to Time the Markets Like an Investing Pro - January 29, 2020 Zacks
Jan-28-20 04:30PM  Agilent Technologies to Webcast First Quarter Fiscal Year 2020 Financial Results Conference Call Business Wire
Jan-27-20 02:00PM  Agilent Introduces New Cutting-Edge SureSelect DNA Kit Business Wire
Jan-23-20 03:04PM  Former CEO claims Youngsville firm's founder is trying to cut him out of a buyout bonus American City Business Journals
08:00AM  Agilent Announces CrossLab Group Leadership Transition Business Wire
Jan-22-20 08:00AM  Agilent Wins Multiple Innovation Awards Business Wire
Jan-16-20 08:00AM  Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema Business Wire
Jan-15-20 02:38PM  Parnassus Endeavor Fund Adds to Cisco, Alphabet
11:45AM  Parnassus Endeavor Fund Invests in Insurance and Logistics in 4th Quarter
Jan-13-20 02:22PM  Agilent Technologies, Inc. (NYSE:A) Delivered A Better ROE Than Its Industry Simply Wall St.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. The company was founded in 1999 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McMullen Michael R.CEO and PresidentMay 15Sale82.506,917570,653504,642May 19 03:36 PM
McMullen Michael R.CEO and PresidentMay 08Sale80.0018,0181,441,440511,559May 11 01:42 PM
McMullen Michael R.CEO and PresidentApr 29Sale78.7213,6031,070,774529,245Apr 30 02:55 PM
McMullen Michael R.CEO and PresidentApr 27Sale76.208,814671,583542,848Apr 28 04:58 PM
Doak MarkSr. Vice PresidentMar 03Sale83.813,494292,832135,678Mar 04 02:09 PM
Doak MarkSr. Vice PresidentMar 02Sale82.002,867235,094139,172Mar 03 01:48 PM
Gonsalves RodneyV.P., Corporate ControllerFeb 25Sale80.021,00080,02443,421Feb 27 01:58 PM
Grau DominiqueSenior Vice PresidentJan 17Option Exercise26.199,033236,574106,530Jan 22 11:27 AM
Grau DominiqueSenior Vice PresidentJan 17Sale90.009,033812,97097,497Jan 22 11:27 AM
Tang MichaelSVP, General Counsel, and Sec.Jan 10Sale87.725,000438,60067,167Jan 14 12:03 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 30Sale85.345,000426,70072,167Jan 02 02:40 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 20Option Exercise40.803,364137,25180,531Dec 20 04:38 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 20Sale85.003,364285,94077,167Dec 20 04:38 PM
Grau DominiqueSenior Vice PresidentDec 12Option Exercise27.197,712209,689105,209Dec 13 07:06 PM
Doak MarkSr. Vice PresidentDec 12Sale84.508,016677,386142,017Dec 13 07:05 PM
Grau DominiqueSenior Vice PresidentDec 12Sale84.007,712647,80897,497Dec 13 07:06 PM
Grau DominiqueSenior Vice PresidentDec 11Sale82.8515,0001,242,69097,498Dec 12 08:37 PM
McMullen Michael R.CEO and PresidentDec 10Option Exercise26.1924,636645,217576,298Dec 13 07:08 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 10Option Exercise40.803,364137,25180,532Dec 12 08:36 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 10Sale82.903,364278,87677,168Dec 12 08:36 PM
McMullen Michael R.CEO and PresidentDec 10Sale82.9024,6362,042,324551,662Dec 13 07:08 PM
McMullen Michael R.CEO and PresidentNov 25Option Exercise26.1924,636645,217576,299Dec 13 07:08 PM
McMullen Michael R.CEO and PresidentNov 25Sale80.0024,6361,970,880551,663Dec 13 07:08 PM
Doak MarkSr. Vice PresidentNov 15Option Exercise21.53612995,912Nov 19 08:04 PM
FIELDS HEIDIDirectorSep 20Sale78.564,000314,2567,311Sep 24 04:44 PM
McMullen Michael R.CEO and PresidentSep 12Option Exercise26.1924,635645,191463,949Sep 16 05:02 PM
McMullen Michael R.CEO and PresidentSep 12Sale77.5024,6351,909,213439,314Sep 16 05:02 PM
FIELDS HEIDIDirectorAug 30Sale70.964,000283,85611,311Sep 04 06:06 PM